Literature DB >> 27635083

RNA Therapeutics for Treatment of Cardiovascular Diseases: Promises and Challenges.

Tina Lucas1, Stefanie Dimmeler2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27635083     DOI: 10.1161/CIRCRESAHA.116.308730

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  5 in total

Review 1.  Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy.

Authors:  Joana Silva; Paula A da Costa Martins
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

2.  Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice.

Authors:  Tina Lucas; Florian Schäfer; Patricia Müller; Sabine A Eming; Alexander Heckel; Stefanie Dimmeler
Journal:  Nat Commun       Date:  2017-05-02       Impact factor: 14.919

3.  MicroRNA-regulated pathways of flow-stimulated angiogenesis and vascular remodeling in vivo.

Authors:  Dominic Henn; Masood Abu-Halima; Dominik Wermke; Florian Falkner; Benjamin Thomas; Christoph Köpple; Nicole Ludwig; Matthias Schulte; Marc A Brockmann; Yoo-Jin Kim; Justin M Sacks; Ulrich Kneser; Andreas Keller; Eckart Meese; Volker J Schmidt
Journal:  J Transl Med       Date:  2019-01-11       Impact factor: 5.531

4.  MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus).

Authors:  David J Coulson; Sherin Bakhashab; Jevi Septyani Latief; Jolanta U Weaver
Journal:  J Transl Med       Date:  2021-04-16       Impact factor: 5.531

Review 5.  Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease.

Authors:  Isabel N Schellinger; Angelika R Dannert; Karin Mattern; Uwe Raaz; Philip S Tsao
Journal:  Front Cardiovasc Med       Date:  2021-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.